Cell Death Discovery (Jun 2021)
Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma
- Surein Arulananda,
- Megan O’Brien,
- Marco Evangelista,
- Tiffany J. Harris,
- Nikita S. Steinohrt,
- Laura J. Jenkins,
- Marzena Walkiewicz,
- Robert J. J. O’Donoghue,
- Ashleigh R. Poh,
- Bibhusal Thapa,
- David S. Williams,
- Trishe Leong,
- John M. Mariadason,
- Xia Li,
- Jonathan Cebon,
- Erinna F. Lee,
- Thomas John,
- W. Douglas Fairlie
Affiliations
- Surein Arulananda
- Olivia Newton-John Cancer Research Institute
- Megan O’Brien
- Olivia Newton-John Cancer Research Institute
- Marco Evangelista
- Olivia Newton-John Cancer Research Institute
- Tiffany J. Harris
- Olivia Newton-John Cancer Research Institute
- Nikita S. Steinohrt
- Olivia Newton-John Cancer Research Institute
- Laura J. Jenkins
- Olivia Newton-John Cancer Research Institute
- Marzena Walkiewicz
- Olivia Newton-John Cancer Research Institute
- Robert J. J. O’Donoghue
- Olivia Newton-John Cancer Research Institute
- Ashleigh R. Poh
- Olivia Newton-John Cancer Research Institute
- Bibhusal Thapa
- Olivia Newton-John Cancer Research Institute
- David S. Williams
- Olivia Newton-John Cancer Research Institute
- Trishe Leong
- Department of Medical Oncology, Austin Health
- John M. Mariadason
- Olivia Newton-John Cancer Research Institute
- Xia Li
- Department of Mathematics and Statistics, La Trobe University
- Jonathan Cebon
- Olivia Newton-John Cancer Research Institute
- Erinna F. Lee
- Olivia Newton-John Cancer Research Institute
- Thomas John
- Olivia Newton-John Cancer Research Institute
- W. Douglas Fairlie
- Olivia Newton-John Cancer Research Institute
- DOI
- https://doi.org/10.1038/s41420-020-00388-7
- Journal volume & issue
-
Vol. 7,
no. 1
pp. 1 – 1
Abstract
No abstracts available.